HER2 Support Group Forums - View Single Post - Everolimus Plus Herceptin Promising in Metastatic Breast Cancer

Lani · 11-11-2010, 10:41 AM

While attempting to see if my previous post was updated for approvals of mTor inhibitors (I quit before I finished the research), I came across this very interesting information:

First of all it is interesting that this might work; second of all, it is funny that Ernest Gallo gave money for such a clinic and research center. Salud(sp?)!

Rapamycin, Approved to Prevent Transplant Rejection, Can Decrease Alcohol Cravings, Ernest Gallo Clinic and Research Center and University of California, San Francisco (UCSF) Study
11/3/2010

Physorg -- Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents. The finding is in a study by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

11-11-2010, 10:41 AM	#5
Lani Senior Member Join Date: Mar 2006 Posts: 4,780	Re: Everolimus Plus Herceptin Promising in Metastatic Breast Cancer While attempting to see if my previous post was updated for approvals of mTor inhibitors (I quit before I finished the research), I came across this very interesting information: First of all it is interesting that this might work; second of all, it is funny that Ernest Gallo gave money for such a clinic and research center. Salud(sp?)! Rapamycin, Approved to Prevent Transplant Rejection, Can Decrease Alcohol Cravings, Ernest Gallo Clinic and Research Center and University of California, San Francisco (UCSF) Study 11/3/2010 Physorg -- Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents. The finding is in a study by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.